DCGI flags regulatory risks as Pharma industry races to embrace AI at IIMA healthcare summit
The DGCI said regulators approve a product based on defined characteristics of quality, safety and performance and expect those characteristics to remain consistent through the product’s lifecycle
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)